Xellia Cleveland manufacturing facility operational for anti-infectives
Xellia Pharmaceuticals launches additional Vanco Ready doses
Xellia Pharmaceuticals expands approved doses of VANCO READYTM
Career Opportunities: Sr Scientist, On Market Products (5942)
Career Opportunities: Global Packaging Manager, Sterile Products (5677)
Career Opportunities: Compliance Quality Assurance Specialist (5667)
Career Opportunities: Automation Engineer (7243)
Career Opportunities: Senior Logistics and Process Engineer (6982)
Xellia Pharmaceuticals reports strong year for 2019 and key business updates
FDA approves Xellia US facility for CMO injectables
Xellia divests North Carolina production facilities to Sagent Pharmaceuticals
Xellia Pharmaceuticals appoints Matthew Anderson as CFO
Xellia Pharmaceuticals appoints Craig Boyd as President of Xellia US
Xellia Pharmaceuticals expands with US$25m investment in Copenhagen
Xellia Pharmaceuticals signs Davos Declaration on
combating Antimicrobial Resistance
